8-KGTBPCIK 0000109657
GT Biopharma, Inc.
Material event (8-K) filed .
Current report announcing a material event, such as an acquisition, executive change, or earnings release.
New to the 8-K? What it is and how to read oneFiling facts
- Accession number
- 0001493152-26-038446
- Filer
- GT Biopharma, Inc.
- Ticker
- GTBP
- CIK
- 0000109657
- Form type
- 8-K
- Form description
- Material event
- Filed at
- August 14, 2026
- Period of report
- August 14, 2026
- Filing size
- 222.4 KB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
More filings from GT Biopharma, Inc.
See all 45 filings from GT Biopharma, Inc. →Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/109657/000149315226038446/0001493152-26-038446-index.htm ↗Filer's full EDGAR submission history
EDGAR · GT Biopharma, Inc. (0000109657) ↗SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.